USPTO serial 79290633
Serial No. 79290633
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 13, 2021
- Examiner
- VELTEN, MALLORY KATE
- Law office
- TMO LAW OFFICE 123
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79290633?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,042*
Plus Government fees of $2,600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey H. Greger
Jeffrey H. Greger Hauptman Ham, LLP2318 Mill Rd.Suite 1400Alexandria, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Soaps for cosmetic use, namely, cosmetic soaps; skin soaps; shampoos; sunscreens for cosmetic use; perfumery products, namely, perfumery, deodorants for personal use; essential oils; body powders; cosmetic products, namely, cosmetics; antiaging creams; hair lotions; cosmetic skin care preparations; skin creams; skin moisturizing gels; face washing creams, facial cleansers, washing products for facial treatment in the nature of non-medicated soaps; moisturizing body lotions; non-medicinal mouthwashes | ACTIVE | — |
| 005 | Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; medical and pharmaceutical preparations, namely, inhaler preparations for treatment of Chronic Obstructive Pulmonary Disease (COPD); preparations containing opium alkaloids; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive cold preparations; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances used in the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation used in the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, and for the treatment of inflammatory disorders, and for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical and biological preparations for the treatment of cancer; dermatological pharmaceutical preparations; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, blood clotting aid and delivery systems for use in human and veterinary medicine; pharmaceutical preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; medicated skin care preparations; medicated skin care preparations, namely, gels; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations for preventing swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint diseases; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelminthics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; analgesic preparations; preparations for the treatment of asthma; preparations for therapeutic or medical purposes, namely, therapeutic medicated skin preparations for treatment of skin diseases; decongestant nasal sprays * pharmaceuticals used in the treatment of erectile dysfunction * | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, spirometers; medical devices, namely, nasal sprayers in the nature of nasal irrigation vessels, inhalers and nebulizers sold empty; medical devices, namely, autoanalysers; chromatographic medical diagnostic apparatus for testing cancer cells | ACTIVE | — |
| 035 | Campaigns for patient support programs, namely, advertising * services * promoting public awareness of cancer patients, pain management, skin care, diabetes management, asthma management, chronic obstructive pulmonary disease (COPD) management and of respiratory disease management | ACTIVE | — |
| 041 | Educational services, namely, providing workshops and seminars in the fields of cancer treatment, oncology, immunology and pain management; publication of journals featuring research articles and clinical trials for pharmaceutical preparations; education services, namely, conducting online instruction and courses in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; training in the use and operation of medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; educational services, namely, providing non-downloadable webinars in the field of health and medical information and distribution of course material in connection therewith; education services, namely, developing, arranging and conducting educational programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; providing training programs and developing training programs in the nature of learning methodologies for others relating to the use and operation of medical devices, medical research apparatus and consultation relating thereto; providing online non-downloadable publications, namely, instructional materials in the nature of worksheets and textbooks, featuring study materials in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; conducting educational seminars in the fields of healthcare, the use of pharmaceuticals, and medical devices, medical research, surgery, medical science and medicine | ACTIVE | — |
| 042 | Scientific research for medical purposes in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis, testing in the field of oncology, immunology and pain management; medical research in the fields of oncology, immunology and pain management; clinical research in the fields of oncology, immunology and pain management; scientific research and development; pharmaceutical drug development services; research and development for new products for others; chemical, pharmaceutical, nutraceutical and nutritional analysis and research; dermo-cosmetic and biotechnological analysis and research; design and testing for new product development; diagnostic product testing and analysis, namely, medical research and new product research for industrial use; scientific research in the fields of chemistry, biotechnology and pharmacology; medical and pharmaceutical research services, scientific research services for medical purposes in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, bacteriological research services, biomedical research services, laboratory research services in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, clinical trial services in the nature of conducting clinical trials for others, pharmacological research services, medical research laboratory services in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, and scientific and technological services and research and design relating thereto, namely, scientific research, analysis, testing in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars * pharmaceutical research and development * | ACTIVE | — |
| 044 | Providing information in the field of medicine and health in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical services in the field of oncology, pain management; dermatology, diabetology, respiratory disease and dietetic advisory services; medical assistance in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; hygiene care for human beings in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical clinic services; dietetic advisory services; disseminating medical information to patients for better lifestyle management to handle the treatment of side effects in the course of treatment of cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases | ACTIVE | — |
| 045 | Licensing of patents; licensing of trademarks; intellectual property licensing in the nature of licensing of intellectual property rights | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ichnos Sciences SA
- Other trademarks owned by Ichnos Sciences SA
- Other trademarks owned by Ichnos Sciences SA
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 13, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 7, 2022 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Nov 15, 2022 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 15, 2022 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Mar 15, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 15, 2022 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Mar 15, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 7, 2022 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Dec 25, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Dec 25, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Nov 29, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 10, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 10, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 13, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 13, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 10, 2021 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jun 6, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 27, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 27, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 24, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 7, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 7, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 7, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 23, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 23, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 23, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 23, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 23, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 23, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 8, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 7, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 3, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 4, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 4, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 3, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 30, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |